Identification
Instrument name
PIXIUM VISION
Symbol
ALPIX
ISIN code
FR0011950641
LEI code
96950046OPLRLKKEOO08
Exchange / Market
Euronext Growth
Trading location
Paris
ICB
Medical Equipment
Website address
Operation
IPO date
Issue type
Transfer
Transfer
Euronext - Euronext Growth

Company profile

Pixium Vision specializes in developing electronic retinal implants. Products are for people having lost their sight due to degenerative eye disorders such as retinitis pigmentosa.

Source: Cofisem - Last Update: 24 Jun 2020
Key Executives
Chief Executive Officer Lloyd Diamond
Chief Financial Officer Didier Laurens
Source: Cofisem - Last Update: 14 Feb 2020
Key figures
Millenium 2019 2018 2017 2016 2015
Net sales 100
Income from ordinary activities 1,718 1,323 2,157
Operating income -8,870 -12,294 -12,666 -15,015 -15,697
Cost (net) of financial indebtedness -883 -921 -749
Equity-accounted companies' contribution to results
Net profit from discontinued activities
Net income -9,876 -13,571 -13,542 -12,441 -15,644
Net income (Group share) -9,876 -13,571 -13,542 -12,441 -15,644
Fiscal year end 12.19 12.18 12.17 12.16 12.15
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 24 Jun 2020
Shareholder information
Flottant 56.95 %
Sofinnova Capital VII FPCI 14.94 %
Concert BPI 13.56 %
Abingworth Holdings Sarl 7.97 %
Omnes Capital 5.49 %
Bernard Gilly 0.61 %
Source: Cofisem - Last Update: 27 Apr 2020